Page last updated: 2024-12-06

2-chloroethyl methanesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID19128
CHEMBL ID275438
SCHEMBL ID2734239
MeSH IDM0255077

Synonyms (39)

Synonym
chloroethyl methanesulfonate
ethanol, 2-chloro-, methanesulfonate
methanesulfonic acid, chloroethyl ester
2-chloroethyl methanesulphonate
einecs 222-672-6
beta-chloroethylmethanesulfonate
ai3-26395
chloroethyl methanesulphonate
brn 1754022
wln: ws1&o2g
nsc18016
methanesulfonic acid, 2-chloroethyl ester
3570-58-9
.beta.-chloroethylmethanesulfonate
nsc 18016
2-chloroethylmethanesulfonate
cb 1506
2-chloroethylmethanesulfonate, puriss
nsc-18016
2-chloroethyl methanesulfonate
2-chloroethyl methanesulfonate, >=99%
methanesulfonic acid 2-chloroethyl ester
C2231
methanesulfonic acid 2-chloro-ethyl ester
CHEMBL275438
AKOS006222794
unii-895h18q125
895h18q125 ,
FT-0634908
SCHEMBL2734239
2-chloroethyl mesylate
DTXSID20189220
mfcd00007560
BS-16652
H11355
Q27269999
CS-W013279
chloroethyl mesylate
SY051715
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID154836Mortality of P388 leukemia in mice at a dose of 100 mg/kg, schedule (q.d.)).1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154062T/C ratio against P388 leukemia in mice at at a dose(mg/kg, schedule (q.d.))1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154059T/C ratio against P388 leukemia in mice at a dose(mg/kg, schedule (q.d.))1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154699weight change difference (T-C) in mice against P388 leukemia at a dose(mg/kg, schedule)1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154061T/C ratio against P388 leukemia in mice at a dose(mg/kg, schedule)1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID227561Compound was evaluated for its ability to exhibit alkylating property toward DNA at 5 mM in 180 min1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Noval antitumor nitrosoureas and related compounds and their reactions with DNA.
AID154060T/C ratio against P388 leukemia in mice at a dose(mg/kg, schedule (q.d.).1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154552Survival time(T/C) of mice against P388 leukemia at a dose of 400 mg/kg, schedule (q.d.); ND means no data1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154698Weight change in mice against P388 leukemia1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154541Survival time(T/C) of mice against P388 leukemia at a dose of 200 mg/kg, schedule (q.d.); ND means no data1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154519Survival time(T/C) of mice against P388 leukemia at a dose of 100 mg/kg, schedule (q.d.); 15.3 treated by 11.4 control1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154985Mortality of P388 leukemia in mice at a dose of 400 mg/kg, schedule (q.d.)); 6 mice dead out of 6 treated mice1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154977Mortality of P388 leukemia in mice at a dose of 200 mg/kg, schedule (q.d.)); 5 mice dead out of 6 treated mice1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154537Survival time(T/C) of mice against P388 leukemia at a dose of 200 mg/kg, schedule (q.d.); 13.1 treated by 11.9 control1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154063T/C ratio against P388 leukemia in mice dose(mg/kg, schedule (q.d.))1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154848Mortality of P388 leukemia in mice at a dose of 200 mg/kg, schedule (q.d.)); 1 mice dead out of 6 treated mice1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154691Survival time(T/C) of mice against P388 leukemia at a dose of 50 mg/kg, schedule (q.d.); Toxic1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
AID154987Mortality of P388 leukemia in mice at a dose of 50 mg/kg, schedule (q.d.)); 0 mice dead out of 6 treated mice1983Journal of medicinal chemistry, Aug, Volume: 26, Issue:8
2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (90.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.88 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]